Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
HyeKyung Han, Sung Eun Kim, Kwang-Hee Shin, Cheolhee Lim, Kyoung Soo Lim, Kyung-Sang Yu & Joo-Youn Cho. (2013) Comparison of pharmacokinetics between new quinolone antibiotics: the zabofloxacin hydrochloride capsule and the zabofloxacin aspartate tablet. Current Medical Research and Opinion 29:10, pages 1349-1355.
Read now
Read now
Pennan M Barry & Jeffrey D Klausner. (2009) The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opinion on Pharmacotherapy 10:4, pages 555-577.
Read now
Read now
John Tapsall. (2006) Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Review of Anti-infective Therapy 4:4, pages 619-628.
Read now
Read now
Articles from other publishers (19)
Soziema E. Dauda, Jessica A. Collins, Jo Ann W. Byl, Yanran Lu, Jack C. Yalowich, Mark J. Mitton-Fry & Neil Osheroff. (2023) Actions of a Novel Bacterial Topoisomerase Inhibitor against Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks. International Journal of Molecular Sciences 24:15, pages 12107.
Crossref
Crossref
A. A. Kubanov, A. T. Leinsoo, A. V. Chestkov, E. I. Dementieva, B. L. Shaskolskiy, V. S. Solomka, D. A. Gryadunov & D. G. Deryabin. (2017) Drug resistance mutations and susceptibility phenotypes of Neisseria gonorrhoeae isolates in Russia. Molecular Biology 51:3, pages 379-388.
Crossref
Crossref
Margaret C. Bash & Kathryn A. Matthias. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
843
865
.
Namraj Goire, David J. Speers, Monica M. Lahra & David M. Whiley. 2015. Human Emerging and Re‐emerging Infections. Human Emerging and Re‐emerging Infections
683
697
.
Katsumi Shigemura, Kayo Osawa, Makiko Miura, Kazushi Tanaka, Soichi Arakawa, Toshiro Shirakawa & Masato Fujisawa. (2015) Azithromycin Resistance and Its Mechanism in Neisseria gonorrhoeae Strains in Hyogo, Japan. Antimicrobial Agents and Chemotherapy 59:5, pages 2695-2699.
Crossref
Crossref
Francis J Ndowa, Catherine A Ison & Manjula Lusti-Narasimhan. (2013) Gonococcal antimicrobial resistance: the implications for public health control. Sexually Transmitted Infections 89:Suppl 4, pages iv1-iv2.
Crossref
Crossref
Jennifer C. Smith, Tim Mailman & Noni E. MacDonald. 2013. Hot Topics in Infection and Immunity in Children IX. Hot Topics in Infection and Immunity in Children IX
219
239
.
O S KOZHUSHNAYA, YE L VASILIYEVA, N V FRIGO & V S SOLOMKA. (2012) Mechanisms of the formation of Neisseria gonorrhoeae resistance to cephalosporins. Vestnik dermatologii i venerologii 88:5, pages 44-51.
Crossref
Crossref
Douglas J. Biedenbach, Lisa L. Turner, Ronald N. Jones & David J. Farrell. (2012) Activity of JNJ-Q2, a novel fluoroquinolone, tested against Neisseria gonorrhoeae, including ciprofloxacin-resistant strains. Diagnostic Microbiology and Infectious Disease 74:2, pages 204-206.
Crossref
Crossref
Hyukmin LeeKyungwon LeeYunsop Chong. (2012)
Antimicrobial Resistance of
Neisseria gonorrhoeae
Isolated in Korea
. Journal of Bacteriology and Virology 42:1, pages 9.
Crossref
Crossref
Eva Tzelepi, Helen Avgerinou, Alexandros Flemetakis, Eirini Siatravani, Maria Stathi, Maria Daniilidou & Vivi Miriagou. (2010) Changing Figures of Antimicrobial Susceptibility and Serovar Distribution in Neisseria gonorrhoeae Isolated in Greece. Sexually Transmitted Diseases 37:2, pages 115-120.
Crossref
Crossref
Margaret C. Bash, Durrie L. McKnew & John W. Tapsall. 2009. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
763
782
.
Karl Drlica, J.-Y. Wang, Muhammad Malik, Tao Lu, Steven Park, Xinying Li, David S. Perlin & Xilin Zhao. 2008. Antimicrobial Resistance and Implications for the Twenty-First Century. Antimicrobial Resistance and Implications for the Twenty-First Century
371
400
.
Michael Dan, Francesca Poch, Ziva Amitai, Dana Gefen & Tamy Shohat. (2006) Pharyngeal Gonorrhea in Female Sex Workers: Response to a Single 2-g Dose of Azithromycin. Sexually Transmitted Diseases 33:8, pages 512-515.
Crossref
Crossref
A. Vera-Tom, F.F. Rodrguez-Vidigal & A. Muoz Sanz. (2006) Infecciones por gonococo. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:55, pages 3585-3590.
Crossref
Crossref
Maria Stathi, Alexandros Flemetakis, Vivi Miriagou, Helen Avgerinou, Kyriakos P. Kyriakis, Antonios N. Maniatis & Eva Tzelepi. (2006) Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994–2004. Journal of Antimicrobial Chemotherapy 57:4, pages 775-779.
Crossref
Crossref
John W. Tapsall. (2006) What Management Is There for Gonorrhea in the Postquinolone Era?. Sexually Transmitted Diseases 33:1, pages 8-10.
Crossref
Crossref
M. Herida, A. Michel, V. Goulet, M. Janier, P. Sednaoui, N. Dupin, B. de Barbeyrac & C. Semaille. (2005) L'épidémiologie des infections sexuellement transmissibles en France. Médecine et Maladies Infectieuses 35:5, pages 281-289.
Crossref
Crossref
F. Van Bambeke, J.-M. Michot, J. Van Eldere & P.M. Tulkens. (2005) Quinolones in 2005: an update. Clinical Microbiology and Infection 11:4, pages 256-280.
Crossref
Crossref